Science and engineering

A study of scientists from South Africa showed that in the body infected with the new strain of the coronavirus "omicron" antibodies are produced that can neutralize the "delta" variant.

It was identified by scientists from the Harvard T.H. Chan School of Public Health with specialists from King's College London.

Two doses of Pfizer and Moderna coronavirus vaccines fail to protect against omicron six months after second vaccination.

The Russian Ministry of Health has registered a drug for treatment of coronavirus MIR 19 developed by the Federal Medical and Biological Agency.

Coronavirus infection in children can lead to a dangerous sepsis-like complication - multisystem inflammation.

Virologist Konstantin Chumakov said that the version of the allegedly artificial origin of the omicron version of the coronavirus is conspiracy theories.

In early 2022, a clinical trial of a vaccine specific to the omicron strain for the coronavirus will begin.

Codeine-containing painkillers can be dangerous to health.

Most often, elderly people become such patients.

In total, the contract with the German company and the American concern provides for the supply of up to 1.8 billion doses of vaccine by the end of 2023.

The Ministry of Health of Belarus has issued a permit for the import and use in the country of the Russian vaccine against coronavirus CoviVac.

In the Republic of South Africa, special conditions are being created for the formation of new strains of coronavirus, since a significant part of the population of this country is infected with the human immunodeficiency virus.

The World Health Organization expects an increase in the number of hospitalizations and deaths due to the Omicron coronavirus strain.

Before that, there were no confirmed deaths from the strain in the world.

Swiss pharmaceutical company Novartis has received permission to use Zolgensma, a drug used to treat spinal muscular atrophy (SMA), in Russia.